Impact Factor 6.429

The 5th most cited journal in Immunology

This article is part of the Research Topic

Etiopathogenesis of Systemic Sclerosis: An Update

Correction ARTICLE

Front. Immunol., 12 April 2017 | https://doi.org/10.3389/fimmu.2017.00381

Corrigendum: Agonistic Anti-PDGF Receptor Autoantibodies from Patients with Systemic Sclerosis Impact Human Pulmonary Artery Smooth Muscle Cells Function In Vitro

imageSilvia Svegliati1†, imageDonatella Amico1†, imageTatiana Spadoni1†, imageColomba Fischetti1, imageDoreen Finke1, imageGianluca Moroncini1, imageChiara Paolini1, imageCecilia Tonnini1, imageAntonella Grieco1, imageMarina Rovinelli1, imageAda Funaro2 and imageArmando Gabrielli1*
  • 1Clinica Medica, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Ancona, Italy
  • 2Dipartimento di Scienze Mediche, Università di Torino, Torino, Italy

A corrigendum on

Agonistic Anti-PDGF Receptor Autoantibodies from Patients with Systemic Sclerosis Impact Human Pulmonary Artery Smooth Muscle Cells Function In Vitro
by Svegliati S, Amico D, Spadoni T, Fischetti C, Finke D, Moroncini G, et al. Front Immunol (2017) 8:75. doi:10.3389/fimmu.2017.00075

In the original article, we neglected to add Ada Funaro as an author. The correct author list and affiliation should be

Silvia Svegliati1†, Donatella Amico1†, Tatiana Spadoni1†, Colomba Fischetti1, Doreen Finke1, Gianluca Moroncini1, Chiara Paolini1, Cecilia Tonnini1, Antonella Grieco1, Marina Rovinelli1, Ada Funaro2 and Armando Gabrielli1*

1Clinica Medica, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Ancona, Italy

2Dipartimento di Scienze Mediche, Università di Torino, Torino, Italy

Author Contributions

SS designed the experimental work analyzed results and wrote the first draft of the manuscript. DA, TS, and MR performed experimental work and analyzed results. CF and DF selected and provided samples and analyzed clinical data. GM, CP, CT, and AGR provided the monoclonal autoantibodies. AF contributed to write the final revised version of the manuscript. AGA designed, supervised, evaluated the experiments, and wrote the final version of the manuscript. All the authors read and approved the manuscript.

The authors apologize for this oversight.

This error does not change the scientific conclusions of the article in any way.

The original article has been updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: systemic sclerosis, autoantibodies, vascular smooth muscle cells, platelet-derived growth factor, synthetic phenotype

Citation: Svegliati S, Amico D, Spadoni T, Fischetti C, Finke D, Moroncini G, Paolini C, Tonnini C, Grieco A, Rovinelli M, Funaro A and Gabrielli A (2017) Corrigendum: Agonistic Anti-PDGF Receptor Autoantibodies from Patients with Systemic Sclerosis Impact Human Pulmonary Artery Smooth Muscle Cells Function In Vitro. Front. Immunol. 8:381. doi: 10.3389/fimmu.2017.00381

Received: 07 March 2017; Accepted: 17 March 2017;
Published: 12 April 2017

Edited and Reviewed by: Raffaele De Palma, Università degli Studi della Campania “Luigi Vanvitelli” Caserta, Italy

Copyright: © 2017 Svegliati, Amico, Spadoni, Fischetti, Finke, Moroncini, Paolini, Tonnini, Grieco, Rovinelli, Funaro and Gabrielli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Armando Gabrielli, a.gabrielli@univpm.it

These authors have contributed equally to this work.